Pivot to the patient

Life sciences is evolving rapidly from selling products to delivering value through a better patient outcomes.

We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.

New science: Biopharma’s new growth engine

Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.

READ MORE

Case studies

New B2B portal improves efficiency for pharmacy partners and helps them better serve patients.

See how we partnered to remove barriers to treatment through mobile technology.

Saving lives and improving the health and well-being of mothers during pregnancy and childbirth

View All

Awards & recognition

Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.

Recognized by Frost & Sullivan

Awarded North American Market Leadership Award - Real World Evidence

2018 Recipient

Recognized by IDC MarketScape

Leader in Life Science R&D Strategic Consulting

2018 Recognition

Recogized by Everest Group

Top Leader — PEAK Matrix Service Provider of the Year

2017 Recipient

View All

A spotlight on women in Life Sciences

We are proud to collaborate with leading women in life sciences in their quest to advance science and patient care.

We were honored when Carol Rohl, the Executive Director of Global Research Information Technology (IT) at Merck Research Labs, agreed to sit down with us to talk about the exciting role that she currently holds. It quickly became apparent how Carol had achieved so much in her career so far, given her warm and open personality.

READ HER STORY

Our leaders

Life Sciences blog

Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.

Finding your roadmap to 2023 DSCSA compliance

Today’s patients are aware of breakthrough treatments but not as privy to the complexities and challenges of data related to their medications.

New Science: Biopharma’s new growth machine

An emerging category in biopharma called “New Science” will shape the treatments and solutions life sciences companies develop.

News

Accenture announces collaboration with Bayer to streamline drug development processes through INTIENT Clinical platform

Accenture has announced a collaboration with Bayer to implement the Accenture INTIENT Clinical platform to help simplify and speed its drug development processes.

Better Collaboration Between Pharma and Patient Organizations Would Improve Patient Care, Accenture Study Finds

Despite preferring services from patient organizations over those from pharmaceutical companies, patients want both to work together to provide a more seamless patient experience.

Subscription Center
Stay in the Know with Our Newsletter Stay in the Know with Our Newsletter